|
Market Closed -
Nasdaq
00:00:00 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.700 USD | +3.45% |
|
-9.28% | +12.69% |
| 11-06 | Verastem, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-06 | RBC Cuts Price Target on Verastem to $18 From $19, Keeps Outperform, Speculative Risk | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERASTEM, INC. | Bio Therapeutic Drugs | +3.45% | -9.28% | +12.69% | +7.81% | -73.54% | 1.1B |  |  | |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
